Tianwei Ellen Zhou, David J Mathew, Karen Wigg, Darren Chan, Jenny Wanyu Zhang, Carmen Balian, Irfan N Kherani, Matthew B Schlenker, Igor Jurisica, Jeremy M Sivak
{"title":"Proteomic Analyses of Early Versus Advanced Primary Open-Angle Glaucoma Uncover Biochemical Signatures Associated With Disease Staging.","authors":"Tianwei Ellen Zhou, David J Mathew, Karen Wigg, Darren Chan, Jenny Wanyu Zhang, Carmen Balian, Irfan N Kherani, Matthew B Schlenker, Igor Jurisica, Jeremy M Sivak","doi":"10.1016/j.mcpro.2026.101625","DOIUrl":null,"url":null,"abstract":"<p><p>Primary open-angle glaucoma (POAG) is a leading cause of blindness, yet the biochemical mechanisms underlying disease progression remain poorly understood. This study characterized aqueous humor (AH) across early and advanced stages of POAG using large-scale proteomics. AH samples were collected from patients with mild POAG, advanced POAG, and non-glaucomatous controls in this prospective cross-sectional study. Profiling of 8000 proteins was performed using an antibody array. Hierarchical clustering, principal component analysis (PCA), Gene Ontology (GO), and pathway enrichment analyses were performed to identify differentially expressed proteins, biological processes, and molecular functions associated with disease stages. Top differential proteins were also correlated with key clinical parameters. Proteomic signatures demonstrated distinct clustering between control and glaucoma patients, with progressive shifts from mild to advanced stages. Comparisons between control and each glaucoma group revealed significant enrichment in pathways related to wound healing, extracellular matrix (ECM) remodeling, and immune responses. Notably, distinct proinflammatory and immune proteins and pathways were enriched when comparing mild to advanced POAG stages. Finally, the top differential AH proteins correlated with multiple clinical endpoints, including intraocular pressure and a variety of retinal outcomes. This signature revealed a tight network associated with disease stage, oriented on immune cell migration and function, and identifying soluble TRPC6 as a novel biomarker. To our knowledge this is the first study to compare large scale proteomic analysis of AH from patients with POAG across disease stages, suggesting new mechanisms underlying glaucoma progression.</p>","PeriodicalId":18712,"journal":{"name":"Molecular & Cellular Proteomics","volume":" ","pages":"101625"},"PeriodicalIF":6.3000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13487834/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular & Cellular Proteomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.mcpro.2026.101625","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Primary open-angle glaucoma (POAG) is a leading cause of blindness, yet the biochemical mechanisms underlying disease progression remain poorly understood. This study characterized aqueous humor (AH) across early and advanced stages of POAG using large-scale proteomics. AH samples were collected from patients with mild POAG, advanced POAG, and non-glaucomatous controls in this prospective cross-sectional study. Profiling of 8000 proteins was performed using an antibody array. Hierarchical clustering, principal component analysis (PCA), Gene Ontology (GO), and pathway enrichment analyses were performed to identify differentially expressed proteins, biological processes, and molecular functions associated with disease stages. Top differential proteins were also correlated with key clinical parameters. Proteomic signatures demonstrated distinct clustering between control and glaucoma patients, with progressive shifts from mild to advanced stages. Comparisons between control and each glaucoma group revealed significant enrichment in pathways related to wound healing, extracellular matrix (ECM) remodeling, and immune responses. Notably, distinct proinflammatory and immune proteins and pathways were enriched when comparing mild to advanced POAG stages. Finally, the top differential AH proteins correlated with multiple clinical endpoints, including intraocular pressure and a variety of retinal outcomes. This signature revealed a tight network associated with disease stage, oriented on immune cell migration and function, and identifying soluble TRPC6 as a novel biomarker. To our knowledge this is the first study to compare large scale proteomic analysis of AH from patients with POAG across disease stages, suggesting new mechanisms underlying glaucoma progression.
期刊介绍:
The mission of MCP is to foster the development and applications of proteomics in both basic and translational research. MCP will publish manuscripts that report significant new biological or clinical discoveries underpinned by proteomic observations across all kingdoms of life. Manuscripts must define the biological roles played by the proteins investigated or their mechanisms of action.
The journal also emphasizes articles that describe innovative new computational methods and technological advancements that will enable future discoveries. Manuscripts describing such approaches do not have to include a solution to a biological problem, but must demonstrate that the technology works as described, is reproducible and is appropriate to uncover yet unknown protein/proteome function or properties using relevant model systems or publicly available data.
Scope:
-Fundamental studies in biology, including integrative "omics" studies, that provide mechanistic insights
-Novel experimental and computational technologies
-Proteogenomic data integration and analysis that enable greater understanding of physiology and disease processes
-Pathway and network analyses of signaling that focus on the roles of post-translational modifications
-Studies of proteome dynamics and quality controls, and their roles in disease
-Studies of evolutionary processes effecting proteome dynamics, quality and regulation
-Chemical proteomics, including mechanisms of drug action
-Proteomics of the immune system and antigen presentation/recognition
-Microbiome proteomics, host-microbe and host-pathogen interactions, and their roles in health and disease
-Clinical and translational studies of human diseases
-Metabolomics to understand functional connections between genes, proteins and phenotypes